Literature DB >> 18093872

Spontaneous HCV clearance in HCV/HIV-1 coinfection associated with normalized CD4 counts, low level of chronic immune activation and high level of T cell function.

Karolin Falconer1, Veronica D Gonzalez, Olle Reichard, Johan K Sandberg, Annette Alaeus.   

Abstract

BACKGROUND/
OBJECTIVE: Spontaneous HCV clearance in HCV/HIV-1 coinfected patients is likely to be very rare given the damage to the immune system caused by HIV-1 infection. The search for immune correlates of spontaneous clearance is important for the understanding of pathogenesis as well as for the development of possible new treatment strategies. STUDY DESIGN/
RESULTS: A cohort of HCV/HIV-1 coinfected patients was followed. Plasma HCV viral load was measured and T cell immunity in peripheral blood samples was assessed using multi-color flow cytometry. One HCV/HIV-1 coinfected patient spontaneously became HCV-RNA negative after being positive for several years. This patient displayed a normalized CD4 counts on successful HAART, low level of T cell activation and a high level of T cell function as compared to HCV/HIV-1 coinfected control subjects.
CONCLUSIONS: A beneficial immune status including a low level of chronic T cell activation and a high level of T cell function may be one factor that contributes to improved chances of clearance of chronic HCV infection in HIV-1 infected patients.

Entities:  

Mesh:

Year:  2008        PMID: 18093872     DOI: 10.1016/j.jcv.2007.11.005

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  6 in total

1.  The human fetal immune response to hepatitis C virus exposure in utero.

Authors:  Jennifer M Babik; Deborah Cohan; Alexander Monto; Dennis J Hartigan-O'Connor; Joseph M McCune
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

2.  Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient.

Authors:  Anil B Seetharam; Brian B Borg; Vijay Subramanian; William C Chapman; Jeffrey S Crippin; Thalachallour Mohanakumar
Journal:  Transplantation       Date:  2011-12-27       Impact factor: 4.939

3.  High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment.

Authors:  Veronica D Gonzalez; Karolin Falconer; Kim G Blom; Olle Reichard; Birgitte Mørn; Alex Lund Laursen; Nina Weis; Annette Alaeus; Johan K Sandberg
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

4.  Spontaneous clearance of chronic hepatitis C is rare in HIV-infected patients after effective use of combination antiretroviral therapy.

Authors:  Mario Frias; Antonio Rivero-Juarez; Francisco Tellez; Monserrat Perez-Perez; Angela Camacho; Isabel Machuca; Sandra Lorenzo-Moncada; Pedro Lopez-Lopez; Antonio Rivero
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

5.  Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy.

Authors:  Adedeji O Majekodunmi; Claire Thorne; Ruslan Malyuta; Alla Volokha; Robin E Callard; Nigel J Klein; Joanna Lewis
Journal:  Pediatr Infect Dis J       Date:  2017-05       Impact factor: 2.129

6.  Chemokine receptor CXCR6 gene polymorphism and treatment response of chronic hepatitis C virus in Egyptian patients.

Authors:  Mona M Hassona; Tamer Fouad; Merhan Osama Helmi; Heba Samy Mohammed Ghanem; Heba E Abd Elrhman; Eman Abdelsameea
Journal:  Clin Exp Hepatol       Date:  2021-12-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.